Debra L. Hanson - Concepedia

Author

Debra L. Hanson

Centers for Disease Control and Prevention

Also Known As

D L Hanson, D. Hanson, D. L. HANSON, D. L. Hanson, D.L. Hanson, DEBRA L. HANSON, Debra Hanson, Debra L Hanson, Debra L. Hanson, Debra L. Hanson

118

Publications

8.6K

Citations

H-Index

122

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention Emory University National Center for Infectious Diseases

About

Debra L. Hanson is an author at Centers for Disease Control and Prevention specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	38	2.5K
2	Public Health	17	18	1.4K
3	Health Sciences	5	5	214
4	Language Studies	1	1	65
5	Natural Sciences	1	1	12

Debra L. Hanson

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003 Pragna Patel, Debra L. Hanson, Patrick S. Sullivan, Annals of Internal Medicine	2008	939
Epidemiology of Anemia in Human Immunodeficiency Virus (HIV)-Infected Persons: Results From the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project Patrick S. Sullivan, Debra L. Hanson, Susan Y. Chu, Blood	1998	428
Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance Paul J. Weidle, Samuel S. Malamba, Raymond Mwebaze, The Lancet Health PolicyTreatment And PreventionGlobal HealthAntiviral TherapyPharmacotherapy	2002	314
Prevalence of Chronic Hepatitis B and Incidence of Acute Hepatitis B Infection in Human Immunodeficiency Virus–Infected Subjects Scott Kellerman, Debra L. Hanson, A. D. McNaghten, The Journal of Infectious Diseases Hepatitis BChronic Hepatitis BPreventive MedicineViral HepatitisClinical Epidemiology	2003	280
Pneumococcal Disease among Human Immunodeficiency Virus-Infected Persons: Incidence, Risk Factors, and Impact of Vaccination Mark S. Dworkin, John W. Ward, Debra L. Hanson, Clinical Infectious Diseases	2001	209
Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine Urvi M. Parikh, Charles Dobard, Sunita Sharma, Journal of Virology	2009	188
Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection J. Gerardo Garcı́a-Lerma, Mian-er Cong, James Mitchell, Science Translational Medicine	2010	169
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users Richard S. Garfein, Elizabeth T. Golub, Alan E. Greenberg, AIDS	2007	167
Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis A. D. McNaghten, Debra L. Hanson, Jeffery L. Jones, AIDS	1999	155
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection Nagadenahalli B. Siddappa, Brianne Kallam, James Arthos, Nature Medicine Mucosal ImmunologyImmunologyAntiviral ResponseGut-associated Lymphoid TissueCd4 T Cell Responses	2014	139

Page 1